Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued on Thursday.
Several other analysts also recently issued reports on ACHC. Mizuho cut their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Guggenheim initiated coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. Royal Bank of Canada reduced their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. KeyCorp dropped their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Finally, Bank of America reduced their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $47.94.
View Our Latest Report on Acadia Healthcare
Acadia Healthcare Stock Performance
ACHC stock traded up $0.82 during trading on Thursday, hitting $23.35. 407,092 shares of the company's stock traded hands, compared to its average volume of 2,277,108. The stock has a market capitalization of $2.15 billion, a price-to-earnings ratio of 7.66, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. Acadia Healthcare has a 52 week low of $20.36 and a 52 week high of $82.40. The stock has a fifty day moving average price of $25.56 and a two-hundred day moving average price of $34.72. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. The business had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company's quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business posted $0.84 EPS. As a group, equities analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
Large investors have recently made changes to their positions in the business. FMR LLC lifted its stake in Acadia Healthcare by 257.9% during the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the last quarter. Citigroup Inc. increased its holdings in shares of Acadia Healthcare by 5,144.2% in the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after buying an additional 2,330,898 shares in the last quarter. Hawk Ridge Capital Management LP lifted its position in shares of Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock valued at $74,988,000 after acquiring an additional 2,013,126 shares during the last quarter. Madison Avenue Partners LP bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $76,339,000. Finally, Abrams Bison Investments LLC acquired a new position in shares of Acadia Healthcare in the 1st quarter worth $55,182,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.